Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasm, Residual 3Small Cell Lung Carcinoma 2Lymphoma, Extranodal NK-T-Cell 2Burkitt Lymphoma 2Subcutaneous panniculitis-like T-cell lymphoma 1Retinoblastoma 1Medulloblastoma 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Myeloid, Acute 1Intracranial Germ Cell Tumors 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Vindesine 1Vincristine 1Rituximab 1Radiation 1Prednisolone 1Methotrexate 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Doxorubicin 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Mediastinal Neoplasms × Etoposide × Clear all
NCT00199082 2022-08-19

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Goethe University

Phase 4 Completed
650 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Mediastinal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡